Loading...
Loading...
India's diclofenac imports from GREECE total $27 across 14 shipments from 2 foreign suppliers. KLEVA PHARMACEUTICALS SA leads with $14 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for diclofenac โ a concentrated sourcing relationship with select suppliers from GREECE.

KLEVA PHARMACEUTICALS SA is the leading Diclofenac supplier from GREECE to India, with import value of $14 across 11 shipments. The top 5 suppliers โ KLEVA PHARMACEUTICALS SA, KELVA PHARMACEUTICALS SA โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | KLEVA PHARMACEUTICALS SA | $14 | 11 | 51.9% |
| 2 |
| KELVA PHARMACEUTICALS SA |
| $13 |
| 3 |
| 48.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $14 | 11 | 51.9% |
| 2 | INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED | $13 | 3 | 48.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Diclofenac suppliers from GREECE to India include KLEVA PHARMACEUTICALS SA, KELVA PHARMACEUTICALS SA. The leading supplier is KLEVA PHARMACEUTICALS SA with import value of $14 USD across 11 shipments. India imported Diclofenac worth $27 USD from GREECE in total across 14 shipments.
India imported Diclofenac worth $27 USD from GREECE across 14 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Diclofenac sourced from GREECE include JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED, INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED. The largest buyer is JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED with $14 in imports across 11 shipments.
The total value of Diclofenac imports from GREECE to India is $27 USD, across 14 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists